Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vifa1g10421 | ATGTCTCTTCTGTTTCTCTTTCTCTCTTTCATTCTCCTTCAACGAGTTTCCTCTCTCAACCAAGAAGGTCTCTACCTGTACCAATTCAAGCTCTCCTTAGACGATCCTGAGTCTTCCCTCTCCTCATGGAACAACCGCGACCAAACACCGTGTAACTGGTCCGGCATAACCTGCAACAACGAAACAACCACCGCCGTGACTCAAATCAACCTCTCCAACTTCAACCTCGCCGGTCCATTACCAACCTCAATCCTCTGTCGTTTAACCAATCTCACCACCCTCATTCTCACCAACAACTCCATCAACCAAACACTACCTCCAGAAATTTCTCTCTGCACCTCCCTTACTCATTTAGACCTCTCTCAAAATCTCCTCACCGGCACACTCCCACAGACCCTACCTCTCCTCACTAACCTCCGTTATCTCGACTTAACGGCTAACAACTTCTCCGGCTCAATCCCCAACTCCTTCGGAACATTCCAGAATCTTCAAGTTATCTCTCTCGTTTACAATCTTCTAGAATCTTCCATTCCTGCTTCTTTAGGAAACATCACCACTCTCAGAACGCTCAATCTCTCTTATAACCCTTTTCAACCTTCTCGGATTCCGCCGGAAATCGGAAACCTAACAAACCTCCAGATTCTCTGGCTTAGTTCATGTAATCTCATTGGTATTATTCCTGACACATTCGGGAATTTGAAGAGACTCACTGTGCTTGATCTTTCCATGAATAATCTTGAAGGTTCTATTCCGAGTTCGCTTGCTTTGATGACGAGTTTGAAGCAGATTGAGCTTTATAATAACTCGTTGTCCGGTGAGTTACCTTCCGGAATGTCGAACCTTACTTCGTTGAGGCTCATTGATGTTGCTATGAATAGTATTGGAGGTGTTATTCCCGATGAGTTGTGCCGTTTACCGCTTGAGAGTCTGAATCTCTATGAAAATCGGTTTACCGGTGATTTGCCGGCCAGTATAGCTGAATCTCCAAATCTCTACGAGTTTAAGATTTTTACGAACTTTTTATCCGGTGAGTTGCCGGAGAATCTCGGGAAGAATGGTCCGTTGATATGGTTTGATGTTTCAAATAATTCATTCTCCGGGAAGATTCCGATGAGCCTGTGCGAGCGCGGCGCATTGGAGGAGTTACTGATGATACATAATTCGTTCTCAGGTGATATTCCAGCGAGTTTGGGTGCTTGTAGAAGTTTGACGCGTGTTAGGTTGGGTTTTAATAATTTGTCCGGACAAGTTCCGGCGGGTTTGTGGGGCTTACCGCATGTGTATCTTCTTGAACTTGTTGACAACTTGTTTACTGGTTCAATTGCTAAGACCATTGGTGGTGCTGGGAATCTGTCTTTGTTGATTGTATCGAATAATAAATTCTCCGGTTCGATTCCTGAAGAGATTGGAAGATTGGAAAGTCTTCAGGAGTTTTCTGGTGGTAATAACCAGTTCAACAATTCGTTGCCTGAGAGTATTGTGAATCTCTCCCAGCTTGGGATTCTTGATCTTCACAACAATAAGATTTCTGGTGAGCTTCCGAAAGGAATTCCATCTCTTAAGAAACTCAACGAGTTGAATTTGGCTAATAATGAGATTGGTGGGAAGATTCCTGAGAAAATTGGCAGTATGTCCGTGCTTAACTTTCTTGATCTTTCCAGTAATCGGTTTTCGGGTAATGTTCCGATGAGTTTGCAGAATTTGAAGCTCAATCAGCTGAATTTGTCTTACAATTTGCTTTCTGGAGAGATTCCACCTCTTATGGCCAAGGCTATGTATAGGGATAGTTTTATCGGTAATCCTGGTTTGTGTGGAGATTTGAAAGGTTTGTGTGATGTCAAAGGAGAAGGGAAGAGTGCTAATTTTGTTTGGCTGCTTAGAGCTATTTTCATAGTTGCAGCTTTGGTTTTTGTCTTTGGTGTGGTTTGGTTCTACTTCAAGTACAGGAATATTAAGAAGGCTAGATCTATTGATAAAACCAAATGGACATTGATGTCATTTCATAAACTGGGTTTTGGTGAAGATGAGGTCTTGAATTGCCTTGATGAAGATAATGTCATTGGAAGTGGATCATCCGGGAAAGTCTACAAGGTTGTGCTTCGCAACGGGGAAGCTGTTGCAGTGAAGAAGATATGGGGAGGGGTTCAAATGGAAACGGAGAGTGGAGATACTGAAAAGAAACAATTTCAAGATAATGCTTTTGATGCAGAGGTTGAAACTTTGGGCAAAATTAGGCACAAGAACATTGTTAAACTATGGTGTTGTTGTACCACTAGGGATTGCAAGCTATTGGTTTACGAGTATATGCCAAATGGTAGTCTTGGTGATTTGCTGCATAGCAATAAAGGAGGATTGTTAGATTGGCCGACTAGGTACAAGATAGCTCTTGATTCTGCAGAAGGCCTCTCTTATCTGCATCATGATTGTGTTCCTCCTATAGTTCATAGAGATGTGAAATCTAATAACATCTTGTTGGATGAAGACTTTAGTGCAAAGGTTGCAGATTTTGGGTTAGCTAAGGCGGTTGAAACCAATGGGAAAGGAACTAAATCCATGTCCGTCATAGCTGGTTCTTGTGGTTATATTGCACCAGAATATGCATACACACTTAGAGTGAACGAGAAGAGTGACACATATAGTTTTGGTGTTGTTATCCTTGAGTTAGTCACTGGAAGGAAGCCGGTAGATCCCGAATTCGGAGAAAAAGACTTAGTTATGTGGGCATGCAACACCTTAGATCAGAAAGGTATCGACCACGTGCTTGACTCGAGGCTTGATTCTTTCTACAAAGAAGAAATTTGCAAGGTCCTCAACATTGGCCTAATGTGCACGAGTCCTCTTCCAATCAACCGGCCCGGAATGAGAAGAGTGGTGAAAATGCTACAAGAGGTAGGCCCTGAAAGCCAATCAAAGTCTTCCCTAAAAGCAGGAAAGTTGTCCCCTTATTACTATGATGATGGGTCAGATCATGGAAGTGTTGCTTAA | 2985 | 0.4265 | MSLLFLFLSFILLQRVSSLNQEGLYLYQFKLSLDDPESSLSSWNNRDQTPCNWSGITCNNETTTAVTQINLSNFNLAGPLPTSILCRLTNLTTLILTNNSINQTLPPEISLCTSLTHLDLSQNLLTGTLPQTLPLLTNLRYLDLTANNFSGSIPNSFGTFQNLQVISLVYNLLESSIPASLGNITTLRTLNLSYNPFQPSRIPPEIGNLTNLQILWLSSCNLIGIIPDTFGNLKRLTVLDLSMNNLEGSIPSSLALMTSLKQIELYNNSLSGELPSGMSNLTSLRLIDVAMNSIGGVIPDELCRLPLESLNLYENRFTGDLPASIAESPNLYEFKIFTNFLSGELPENLGKNGPLIWFDVSNNSFSGKIPMSLCERGALEELLMIHNSFSGDIPASLGACRSLTRVRLGFNNLSGQVPAGLWGLPHVYLLELVDNLFTGSIAKTIGGAGNLSLLIVSNNKFSGSIPEEIGRLESLQEFSGGNNQFNNSLPESIVNLSQLGILDLHNNKISGELPKGIPSLKKLNELNLANNEIGGKIPEKIGSMSVLNFLDLSSNRFSGNVPMSLQNLKLNQLNLSYNLLSGEIPPLMAKAMYRDSFIGNPGLCGDLKGLCDVKGEGKSANFVWLLRAIFIVAALVFVFGVVWFYFKYRNIKKARSIDKTKWTLMSFHKLGFGEDEVLNCLDEDNVIGSGSSGKVYKVVLRNGEAVAVKKIWGGVQMETESGDTEKKQFQDNAFDAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSNKGGLLDWPTRYKIALDSAEGLSYLHHDCVPPIVHRDVKSNNILLDEDFSAKVADFGLAKAVETNGKGTKSMSVIAGSCGYIAPEYAYTLRVNEKSDTYSFGVVILELVTGRKPVDPEFGEKDLVMWACNTLDQKGIDHVLDSRLDSFYKEEICKVLNIGLMCTSPLPINRPGMRRVVKMLQEVGPESQSKSSLKAGKLSPYYYDDGSDHGSVA | 994 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vifa1g10421 | 994 | PANTHER | LRR RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE-RELATED | 186 | 963 | - | - | |
Vifa1g10421 | 994 | FunFam | Leucine-rich repeat receptor-like serine/threonine-protein kinase | 769 | 978 | - | - | |
Vifa1g10421 | 994 | ProSiteProfiles | Leucine-rich repeat profile. | 235 | 257 | IPR001611 | GO:0005515 | |
Vifa1g10421 | 994 | FunFam | Receptor-like protein kinase HSL1 | 665 | 768 | - | - | |
Vifa1g10421 | 994 | SMART | serkin_6 | 681 | 983 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa1g10421 | 994 | Gene3D | Ribonuclease Inhibitor | 200 | 306 | IPR032675 | - | |
Vifa1g10421 | 994 | Gene3D | Transferase(Phosphotransferase) domain 1 | 769 | 982 | - | - | |
Vifa1g10421 | 994 | Pfam | Protein kinase domain | 683 | 900 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa1g10421 | 994 | SUPERFAMILY | RNI-like | 307 | 591 | - | - | |
Vifa1g10421 | 994 | PRINTS | Leucine-rich repeat signature | 233 | 246 | - | - | |
Vifa1g10421 | 994 | PRINTS | Leucine-rich repeat signature | 115 | 128 | - | - | |
Vifa1g10421 | 994 | FunFam | LRR receptor-like serine/threonine-protein kinase ERL1 | 19 | 181 | - | - | |
Vifa1g10421 | 994 | Pfam | Leucine rich repeat N-terminal domain | 20 | 59 | IPR013210 | - | |
Vifa1g10421 | 994 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 813 | 825 | IPR008271 | GO:0004672|GO:0006468 | |
Vifa1g10421 | 994 | Pfam | Leucine rich repeat | 210 | 270 | IPR001611 | GO:0005515 | |
Vifa1g10421 | 994 | Pfam | Leucine rich repeat | 137 | 196 | IPR001611 | GO:0005515 | |
Vifa1g10421 | 994 | ProSiteProfiles | Protein kinase domain profile. | 681 | 964 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa1g10421 | 994 | SUPERFAMILY | Protein kinase-like (PK-like) | 677 | 961 | IPR011009 | - | |
Vifa1g10421 | 994 | ProSitePatterns | Protein kinases ATP-binding region signature. | 687 | 710 | IPR017441 | GO:0005524 | |
Vifa1g10421 | 994 | FunFam | Receptor-like protein kinase HSL1 | 306 | 613 | - | - | |
Vifa1g10421 | 994 | MobiDBLite | consensus disorder prediction | 968 | 994 | - | - | |
Vifa1g10421 | 994 | Gene3D | Ribonuclease Inhibitor | 307 | 616 | IPR032675 | - | |
Vifa1g10421 | 994 | SMART | LRR_typ_2 | 520 | 544 | IPR003591 | - | |
Vifa1g10421 | 994 | SMART | LRR_typ_2 | 136 | 162 | IPR003591 | - | |
Vifa1g10421 | 994 | SMART | LRR_typ_2 | 496 | 519 | IPR003591 | - | |
Vifa1g10421 | 994 | SMART | LRR_typ_2 | 184 | 208 | IPR003591 | - | |
Vifa1g10421 | 994 | SMART | LRR_typ_2 | 88 | 112 | IPR003591 | - | |
Vifa1g10421 | 994 | SMART | LRR_typ_2 | 233 | 256 | IPR003591 | - | |
Vifa1g10421 | 994 | SMART | LRR_typ_2 | 209 | 232 | IPR003591 | - | |
Vifa1g10421 | 994 | SMART | LRR_typ_2 | 257 | 281 | IPR003591 | - | |
Vifa1g10421 | 994 | Gene3D | Phosphorylase Kinase; domain 1 | 666 | 768 | - | - | |
Vifa1g10421 | 994 | SUPERFAMILY | L domain-like | 35 | 374 | - | - | |
Vifa1g10421 | 994 | Gene3D | Ribonuclease Inhibitor | 18 | 199 | IPR032675 | - | |
Vifa1g10421 | 994 | FunFam | LRR receptor-like serine/threonine-protein kinase ERECTA | 182 | 274 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vifa1g10421 | Vifa-Chr1 | 1741237316 | 1741240460 | Dispersed/Wgd |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vifa1g10421 | 16 | 994 | Receptor kinase-like Gene Family | AT1G28440 | 67.241 | 0.0 | 1362 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-XI-1 | Vifa1g10421 | Pkinase | 2.6e-43 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Vifa1g10421 | - | - | gmx:100776936 | 1499.18 |